Arcadia Biosciences (RKDA) Return on Sales (2014 - 2025)

Arcadia Biosciences has reported Return on Sales for 12 years, with the latest figure at 0.0% in Q3 2025.

• For the quarter ending Q3 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Sep 2025 stood at 0.0% (up 2.0% YoY), and the FY2024 full-year result was 0.01%, up 1.0% from the prior year.
• Return on Sales for Q3 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.01% in Q4 2021, with the low at 0.09% in Q4 2023.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.0% in 2024.
• The largest YoY upside for Return on Sales was 24 bps in 2021 against a maximum downside of 14 bps in 2021.
• Arcadia Biosciences' Return on Sales stood at 0.01% in 2021, then tumbled by 85 bps to 0.0% in 2022, then tumbled by 4821 bps to 0.09% in 2023, then jumped by 100 bps to 0.0% in 2024, then jumped by 76 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025), per Business Quant data.